2026年9月23日 15:31 ET 发布 · 更新于 2 个月前 · 1 个来源
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
TechCrunch
·
原始报道
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
原文